Literature DB >> 17497699

Abnormal vertebral segmentation and the notch signaling pathway in man.

Peter D Turnpenny1, Ben Alman, Alberto S Cornier, Philip F Giampietro, Amaka Offiah, Olivier Tassy, Olivier Pourquié, Kenro Kusumi, Sally Dunwoodie.   

Abstract

Abnormal vertebral segmentation (AVS) in man is a relatively common congenital malformation but cannot be subjected to the scientific analysis that is applied in animal models. Nevertheless, some spectacular advances in the cell biology and molecular genetics of somitogenesis in animal models have proved to be directly relevant to human disease. Some advances in our understanding have come through DNA linkage analysis in families demonstrating a clustering of AVS cases, as well as adopting a candidate gene approach. Only rarely do AVS phenotypes follow clear Mendelian inheritance, but three genes-DLL3, MESP2, and LNFG-have now been identified for spondylocostal dysostosis (SCD). SCD is characterized by extensive hemivertebrae, trunkal shortening, and abnormally aligned ribs with points of fusion. In familial cases clearly following a Mendelian pattern, autosomal recessive inheritance is more common than autosomal dominant and the genes identified are functional within the Notch signaling pathway. Other genes within the pathway cause diverse phenotypes such as Alagille syndrome (AGS) and CADASIL, conditions that may have their origin in defective vasculogenesis. Here, we deal mainly with SCD and AGS, and present a new classification system for AVS phenotypes, for which, hitherto, the terminology has been inconsistent and confusing. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17497699     DOI: 10.1002/dvdy.21182

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  49 in total

Review 1.  Alagille syndrome: pathogenesis, diagnosis and management.

Authors:  Peter D Turnpenny; Sian Ellard
Journal:  Eur J Hum Genet       Date:  2011-09-21       Impact factor: 4.246

Review 2.  Canonical and non-canonical Notch ligands.

Authors:  Brendan D'Souza; Laurence Meloty-Kapella; Gerry Weinmaster
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

Review 3.  Notch signaling in human development and disease.

Authors:  Andrea L Penton; Laura D Leonard; Nancy B Spinner
Journal:  Semin Cell Dev Biol       Date:  2012-01-28       Impact factor: 7.727

Review 4.  Notch regulation of bone development and remodeling and related skeletal disorders.

Authors:  Stefano Zanotti; Ernesto Canalis
Journal:  Calcif Tissue Int       Date:  2011-10-16       Impact factor: 4.333

5.  Putative binding sites for mir-125 family miRNAs in the mouse Lfng 3'UTR affect transcript expression in the segmentation clock, but mir-125a-5p is dispensable for normal somitogenesis.

Authors:  Kanu Wahi; Sophia Friesen; Vincenzo Coppola; Susan E Cole
Journal:  Dev Dyn       Date:  2017-08-18       Impact factor: 3.780

Review 6.  The many facets of Notch ligands.

Authors:  B D'Souza; A Miyamoto; G Weinmaster
Journal:  Oncogene       Date:  2008-09-01       Impact factor: 9.867

Review 7.  A fluorescence spotlight on the clockwork development and metabolism of bone.

Authors:  Tadahiro Iimura; Ayako Nakane; Mayu Sugiyama; Hiroki Sato; Yuji Makino; Takashi Watanabe; Yuzo Takagi; Rika Numano; Akira Yamaguchi
Journal:  J Bone Miner Metab       Date:  2011-07-16       Impact factor: 2.626

Review 8.  Making and breaking symmetry in development, growth and disease.

Authors:  Daniel T Grimes
Journal:  Development       Date:  2019-08-15       Impact factor: 6.868

9.  Two novel missense mutations in HAIRY-AND-ENHANCER-OF-SPLIT-7 in a family with spondylocostal dysostosis.

Authors:  Duncan B Sparrow; David Sillence; Merridee A Wouters; Peter D Turnpenny; Sally L Dunwoodie
Journal:  Eur J Hum Genet       Date:  2010-01-20       Impact factor: 4.246

Review 10.  The segmentation clock mechanism moves up a notch.

Authors:  Sarah Gibb; Miguel Maroto; J Kim Dale
Journal:  Trends Cell Biol       Date:  2010-08-18       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.